Over 1600 Total Lots Up For Auction at Four Locations - NJ Cleansweep 05/07, NJ Cleansweep 05/08, CA 05/09, CO 05/12

Dr. Carri Glide-Hurst

American Association of Physicists in Medicine elects fellow
September 04, 2018
Rad Oncology Radiation Therapy
Dr. Carri Glide-Hurst
DETROIT – Henry Ford Cancer Institute medical physicist Carri K. Glide-Hurst, Ph.D., DABR, has been elected to be a Fellow of the American Association of Physicists in Medicine (AAPM), a prestigious international organization of 8,500 medical physicists in 93 countries.

Dr. Glide-Hurst, the director of Translational Research in Radiation Oncology at Henry Ford, was presented with the fellowship award at the Annual Meeting of the American Association of Physicists in Medicine in Nashville, TN.

The category of AAPM Fellow honors members who have distinguished themselves by their contributions in research, education, or leadership in the medical physics community. The AAPM supports the medical physics community with a focus on advancing patient care through education, improving safety and efficacy of radiation oncology and medical imaging procedures through research, and the maintenance of professional standards.
stats
DOTmed text ad

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

stats
Dr. Glide-Hurst is nationally recognized for work with magnetic resonance simulation (MR-SIM) and MR‐guided radiation therapy, including implementation at the Henry Ford Cancer Institute of the world’s first FDA-approved linear accelerator-based MRI-guided radiation therapy system, ViewRay MRIdian Linac.

Additionally, Dr. Glide-Hurst was awarded a prestigious NIH R01 on MR-only treatment planning and is primary investigator or co-primary investigator on 11 other grants. She has published 48 manuscripts, four book chapters, 125 abstracts, and holds one patent.

She serves on nine AAPM committees, most notably the Strategic Planning Committee, Board of Directors, co-chair of TG-284 on MR-SIM, Annual Meeting Scientific Track co-director, and AAPM Summer School faculty. She also serves on ABR Medical Physics Parts 2 and 3 Therapy Exam Committees.

Dr. Glide-Hurst also has a passion for mentoring future physicists. During her career, she has mentored 14 residents and 17 researchers.

Dr. Glide-Hurst received a Ph.D. in medical physics from Wayne State University and completed two years of postdoctoral training at Beaumont Health.

You Must Be Logged In To Post A Comment

 

Rad Oncology Homepage

Will you be attending this year's National Proton Conference?
Q&A with Jennifer Maggiore, the National Association for Proton Therapy’s (NAPT) executive director
Varian and Embolx to jointly market embolization microcatheter in US
Expanding interventional oncology portfolio with a focus on liver-directed therapies
FDA clears Novartis’ Pluvicto for earlier use in PSMA-positive prostate cancer
Approved for patients who received one androgen receptor pathway inhibitor (ARPI) but not chemotherapy
World Theranostics Day: The dawn of precision cancer care
Insights from Dr. Ilya Gipp, oncology chief medical officer at GE HealthCare
Eckert & Ziegler to supply lu-177 to AtomVie under new global agreement
Increasingly used in targeted radiopharmaceutical therapies for various cancers
Congress reintroduces ROCR Act to reform Medicare payments for radiation therapy
Seeks to replace per-treatment reimbursement model with episode-based system
More than 16,000 more linear accelerators needed to meet global demand by 2045: study
Researchers highlight urgent need for investment in global radiotherapy infrastructure
RefleXion expands SCINTIX radiotherapy with first freestanding cancer center install
X1 platform provides biology-guided treatment in real time
University Hospitals to build $39 million regional cancer hub at UH TriPoint in Ohio
Follows similar expansions at UH Avon and UH Minoff health centers
The Case FOR radiologic detection & diagnosis versus blood, urine and hormone testing.
ProstatID: A Smarter, Non-Invasive Approach to Prostate Cancer Detection